CDXS Codexis, Inc. - Common Stock
$1,57
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$1–$3
29% of range
Analystenbewertung
BUY
13 analysts
Kursziel
$7
+321% upside
P/E (TTM)
-3.1
ROE
-82.8%
Nettogewinnmarge
-62.5%
Über Codexis, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Mehr lesen
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
History
Codexis is based in Redwood City, CA and was incorporated in 2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio.
Pharmaceutical
Codexis won the Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency (EPA) in 2006 for its work on a building block of Lipitor. It then won a second time in 2010 for its work with Merck & Co. on the active ingredient in Januvia.
Nutrition
In 2017, the company entered a partnership with Tate & Lyle to provide research and development for the production of new ingredients. That same year, Codexis announced a collaboration with Nestle to provide enzymes for metabolic disorders.
Biotherapeutics
In 2017, Codexis developed a recombinant phenylalanine ammonia-lyase (PAL) enzyme, to act as a substitute phenylalanine hydroxylase (PAH) enzyme for people who suffer from phenylketonuria. The enzyme was in-licensed by Nestle Health Sciences.
In 2020, Takeda Pharmaceutical announced a collaboration with Codexis to research and create gene therapies for rare diseases, including lysosomal storage disorders.
Life science
In June 2020, they announced a partnership with Molecular Assemblies to engineer enzymes for DNA synthesis.
Technology
Codexis uses directed evolution to develop its enzymes. Using this method, scientists genetically engineer genes, then screen the enzymes produced to see if it creates the properties needed for a specific reaction. Their protein engineering platform, called CodeEvolver, uses machine learning and high-throughput experimentation to learn protein sequence changes and their impacts on protein function.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
CDXS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.56
Marktkapitalisierung
$142M
P/E (TTM)
-3.1
EPS (TTM)
$-0.50
Umsatz (TTM)
$70M
Dividendenrendite
—
ROE
-82.8%
Verschuldungsgrad
0.8
52W-Spanne
$1 – $3
CDXS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$70M
2016-12-31
→
2025-12-31
EPS
$-0.50
2019-12-31
→
2025-12-31
Freier Cashflow
$-24M
2016-12-31
→
2025-12-31
Margen
-62.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CDXS
Peer-Median
P/E (TTM)
-3.1
17.5
P/S (TTM) (K/V (TTM))
2.0
3.3
P/B (K/B)
2.8
2.1
EV / EBITDA
-2.8
—
Price / FCF (Kurs / FCF)
-5.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CDXS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-59.3%
—
Net Profit Margin (Nettogewinnmarge)
-62.5%
-56.5%
ROA
-29.6%
-17.2%
ROE
-82.8%
-41.3%
ROIC
-46.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CDXS
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.8
369.6
Current Ratio (Liquiditätsgrad)
3.8
4.9
Quick Ratio
3.1
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CDXS
Peer-Median
Revenue YoY (Umsatz YoY)
18.6%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-20.2%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
0.38%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CDXS
Peer-Median
CDXS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
13 Analysten
- Starker Kauf 4 30,8%
- Kauf 6 46,2%
- Halten 3 23,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
6 Analysten · 2026-08-13
Median
$7.00
← Unter allen Zielen
$1.56
Tief
$2.00
Hoch
$11.00
Median-Ziel
$7.00
+347,3%
Mittelwert-Ziel
$6.58
+320,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.13 | $-0.14 | 0.01% |
| 31. März 2026 | $-0.10 | $-0.14 | 0.04% |
| 31. Dezember 2025 | $0.11 | $-0.04 | 0.15% |
| 30. September 2025 | $-0.22 | $-0.15 | -0.07% |
| 30. Juni 2025 | $-0.16 | $-0.19 | 0.03% |
| 31. März 2025 | $-0.25 | $-0.24 | -0.01% |
| 31. Dezember 2024 | $-0.13 | $-0.04 | -0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| QSI | — | — | — | — | — | — |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| SEER | — | -1.4 | 17.0% | — | — | — |
| NAUT | $247M | -4.1 | — | — | -34.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Cost of Revenue | $9M | $16M | $13M | $38M | $22M | $14M | $16M | $13M | $14M | $10M | $7M | $10M | |
| R&D Expense | $52M | $46M | $59M | $80M | $56M | $44M | $34M | $30M | $30M | $22M | $21M | $23M | |
| SG&A Expense | $47M | $55M | $53M | $52M | $49M | $35M | $32M | $29M | $29M | $25M | $22M | $22M | |
| Operating Expenses | $112M | $118M | $138M | $173M | $127M | $93M | $81M | $72M | $73M | $57M | $50M | $54M | |
| Operating Income | $-42M | $-59M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Interest Income | $3M | $4M | $4M | $1M | $459.0K | $405.0K | $1M | $671.0K | $147.0K | $60.0K | $19.0K | $18.0K | |
| Other Non-op | $-5M | $-10M | $-12M | $124.0K | $1M | $-156.0K | $-656.0K | $-291.0K | $-92.0K | $-94.0K | · | · | |
| Pretax Income | $-44M | $-65M | $-76M | $-33M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Income Tax | $47.0K | $34.0K | $69.0K | $276.0K | $189.0K | $339.0K | $17.0K | $-37.0K | $81.0K | $-40.0K | $-338.0K | $-256.0K | |
| Net Income | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| EPS (Basic) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| EPS (Diluted) | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 | $-0.40 | $-0.21 | · | · | · | · | · | |
| Shares (Basic) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| Shares (Diluted) | 87,142,000 | 73,408,000 | 68,131,000 | 65,344,000 | 64,568,000 | 59,360,000 | 56,525,000 | · | · | · | · | · | |
| EBITDA | $-36M | $-54M | $-68M | $-35M | $-23M | $-24M | $-13M | $-11M | $-23M | $-9M | $-8M | $-19M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $19M | $65M | $114M | $117M | $149M | $90M | $53M | $31M | $19M | $23M | $26M | |
| Short-term Investments | $27M | $54M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | $10M | $32M | $25M | $14M | $9M | $12M | $11M | $6M | $7M | $4M | |
| Inventory | $2M | $2M | $3M | $2M | $1M | $964.0K | $371.0K | $589.0K | $1M | $825.0K | $992.0K | $1M | |
| Prepaid Expense | $6M | $4M | $5M | $5M | $6M | $3M | $3M | $1M | $984.0K | $1M | $1M | $1M | |
| Other Current Assets | $500.0K | $500.0K | $600.0K | $700.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $97M | $99M | $93M | $163M | $162M | $184M | $114M | $68M | $45M | $27M | $33M | $33M | |
| PP&E (Net) | $13M | $14M | $15M | $23M | $21M | $10M | $6M | $5M | $3M | $2M | $3M | $4M | |
| PP&E (Gross) | $58M | $55M | $55M | $62M | $57M | $43M | $40M | $38M | $35M | $34M | $35M | $37M | |
| Accum. Depreciation | $45M | $41M | $39M | $40M | $36M | $33M | $33M | $33M | $32M | $32M | $32M | $31M | |
| Goodwill | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | · | · | · | · | · | · | · | · | · | $0 | $3M | $6M | |
| Other Non-current Assets | $883.0K | $1M | $1M | $350.0K | $276.0K | $294.0K | $178.0K | $1M | $302.0K | $259.0K | $310.0K | $294.0K | |
| Total Assets | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Accounts Payable | $2M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $5M | |
| Accrued Liabilities | $3M | $6M | $5M | $15M | $13M | $10M | $7M | $5M | $4M | $2M | $2M | $3M | |
| Current Liabilities | $25M | $24M | $36M | $49M | $33M | $25M | $15M | $18M | $25M | $12M | $15M | $14M | |
| Capital Leases | $30M | $28M | $12M | $38M | $44M | $22M | $25M | $61.0K | $302.0K | · | · | · | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $97M | $82M | $50M | $106M | $82M | $52M | $44M | $23M | $29M | $17M | $22M | · | |
| Long-term Debt | $40M | $29M | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $40M | $29M | · | · | · | · | · | · | $302.0K | · | · | · | |
| Common Stock | $9.0K | $8.0K | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | |
| Paid-in Capital | $657M | $630M | $584M | $566M | $552M | $537M | $448M | $387M | $340M | $311M | $306M | $302M | |
| Retained Earnings | $-607M | $-563M | $-498M | $-421M | $-388M | $-366M | $-342M | $-330M | $-315M | $-292M | $-284M | $-276M | |
| AOCI | $8.0K | $52.0K | $0 | · | · | · | · | $0 | $-472.0K | $0 | $405.0K | $-142.0K | |
| Stockholders' Equity | $51M | $67M | $87M | $145M | $164M | $170M | $106M | $56M | $25M | $19M | $23M | $26M | |
| Liabilities + Equity | $148M | $149M | $137M | $250M | $246M | $222M | $149M | $79M | $54M | $36M | $45M | $48M | |
| Shares Outstanding | 90,478,000 | 81,850,000 | 69,905,000 | 65,811,000 | 65,109,000 | 64,283,000 | 58,877,000 | 54,065,000 | 48,365,000 | 41,255,000 | 40,343,000 | 39,563,000 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $5M | $5M | $6M | $5M | · | · | · | · | · | · | · | · | |
| Stock-based Comp | $10M | $13M | $10M | $15M | $12M | $8M | $7M | $8M | $7M | $6M | $5M | $5M | |
| Deferred Tax | $-3.0K | $-2.0K | $0 | $-7.0K | $-9.0K | $-8.0K | $-6.0K | $-29.0K | $12.0K | $-31.0K | $-330.0K | $110.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $0 | $3M | $3M | $3M | |
| Restructuring | $3M | $0 | $3M | $3M | $0 | $0 | · | · | · | · | · | · | |
| Other Non-cash | $10M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-19M | $-49M | $-53M | $11M | $-14M | $-16M | $-13M | $-14M | $-9M | $-2M | $-433.0K | $321.0K | |
| CapEx | $4M | $4M | $4M | $8M | $14M | $4M | $4M | $3M | $985.0K | $888.0K | $1M | $302.0K | |
| Investing Cash Flow | $24M | $-57M | $-5M | $-14M | $-21M | $-6M | $-4M | $-3M | $-983.0K | $-846.0K | $-1M | $5M | |
| Debt Issued | $10M | $30M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $10M | $30M | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $17M | $31M | $9M | $0 | $0 | $86M | $0 | $37M | $24M | $0 | $0 | $9.0K | |
| Net Stock Activity | $17M | $31M | $9M | $0 | $0 | $86M | $50M | · | $24M | $0 | $0 | $9.0K | |
| Financing Cash Flow | $28M | $61M | $8M | $-575.0K | $4M | $81M | $54M | $39M | $22M | $-490.0K | $-2M | $-611.0K | |
| Net Change in Cash | $32M | $-46M | $-49M | $-3M | $-32M | $59M | $38M | $22M | $12M | $-3M | $-3M | $4M | |
| Taxes Paid | · | $17.0K | $194.0K | $100.0K | $102.0K | $312.0K | $5.0K | $5.0K | $32.0K | $5.0K | $8.0K | $15.0K | |
| Free Cash Flow | $-24M | $-54M | $-57M | $3M | $-28M | $-20M | $-16M | $-17M | $-10M | $-4M | $-2M | $19.0K |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| Net Margin | -62.5% | -110.0% | -108.7% | -24.2% | -20.3% | -34.8% | -17.4% | -17.9% | -46.0% | -17.5% | -18.1% | -54.0% | |
| Pretax Margin | -62.4% | -109.9% | -108.6% | -24.0% | -20.1% | -34.3% | -17.4% | -18.0% | -45.8% | -17.6% | -18.9% | -54.7% | |
| EBITDA Margin | -51.8% | -90.3% | -97.0% | -25.2% | -21.7% | -34.6% | -18.3% | -18.6% | -45.9% | -17.5% | -18.6% | -54.1% | |
| ROA | -29.6% | -45.7% | -39.4% | -13.5% | -9.1% | -13.0% | -10.4% | -16.4% | -51.5% | -21.3% | -16.3% | -35.7% | |
| ROE | -82.8% | -93.0% | -85.6% | -22.5% | -12.8% | -18.4% | -11.5% | -19.6% | -98.6% | -40.8% | -30.8% | -56.3% | |
| ROIC | -46.1% | -61.1% | -78.7% | -24.3% | -13.9% | -14.3% | -11.9% | -20.0% | -92.8% | -44.6% | -32.5% | -71.7% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 | 7.4 | 7.4 | 3.8 | 1.8 | 2.2 | 2.2 | 2.4 | |
| Quick Ratio | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 | 6.5 | 6.5 | 3.6 | 1.7 | 2.0 | 2.1 | 2.2 | |
| Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · | |
| LT Debt / Equity | 0.8 | 0.4 | · | · | · | · | · | · | 0.0 | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.6 | 0.9 | 1.1 | 1.2 | 0.9 | 0.7 | |
| Inventory Turnover | 5.2 | 7.3 | 5.4 | 23.9 | 20.9 | 20.6 | 32.6 | 15.5 | 15.4 | 10.7 | 5.5 | 6.7 | |
| Receivables Turnover | · | · | 3.3 | 4.9 | 5.4 | 6.0 | 6.7 | 5.3 | 5.6 | 7.4 | 7.5 | 7.6 |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 18.6% | -15.4% | -49.4% | 32.3% | 51.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -20.2% | -17.3% | 0.52% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.38% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $70M | $59M | $70M | $139M | $105M | $69M | $68M | $61M | $50M | $49M | $42M | $35M | |
| Net Income TTM | $-44M | $-65M | $-76M | $-34M | $-21M | $-24M | $-12M | $-11M | $-23M | $-9M | $-8M | $-19M | |
| Market Cap | $147M | $390M | $213M | $307M | $2.04B | $1.40B | $941M | $912M | $404M | $190M | $171M | $100M | |
| Enterprise Value | $109M | $346M | · | · | · | · | · | · | $373M | · | · | · | |
| P/E | -3.3 | -5.4 | -2.7 | -9.1 | -94.8 | -54.6 | -76.1 | · | · | · | · | · | |
| P/S | 2.1 | 6.6 | 3.0 | 2.2 | 19.4 | 20.3 | 13.8 | 15.0 | 8.1 | 3.9 | 4.1 | 2.8 | |
| P/B | 2.9 | 5.8 | 2.5 | 2.1 | 12.4 | 8.2 | 8.9 | 16.2 | 16.5 | 9.9 | 7.5 | 3.8 | |
| P / Tangible Book | 3.1 | 6.1 | 2.5 | 2.2 | 12.6 | 8.4 | · | · | · | · | · | · | |
| P / Cash Flow | -7.6 | -7.9 | -4.1 | 27.2 | -142.7 | -85.2 | -75.0 | -64.7 | -46.1 | -70.3 | -394.1 | 310.6 | |
| P / FCF | -6.2 | -7.3 | -3.7 | 103.0 | -72.5 | -69.4 | -57.8 | -54.1 | -41.4 | -52.9 | -104.6 | 5247.3 | |
| EV / EBITDA | -3.0 | -6.5 | · | · | · | · | · | · | -16.2 | · | · | · | |
| EV / FCF | -4.6 | -6.4 | · | · | · | · | · | · | -38.3 | · | · | · | |
| EV / Revenue | 1.6 | 5.8 | · | · | · | · | · | · | 7.5 | · | · | · | |
| Earnings Yield | -30.7% | -18.7% | -36.7% | -10.9% | -1.1% | -1.8% | -1.3% | · | · | · | · | · |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $15M | $39M | $9M | $15M | $8M | $21M | $13M | $8M | $17M | $27M | $9M | $21M | $13M | $30M | $34M | |
| Cost of Revenue | $4M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $3M | $5M | $3M | $2M | $3M | $5M | $8M | $10M | |
| R&D Expense | $12M | $11M | $12M | $14M | $14M | $13M | $12M | $12M | $11M | $11M | $11M | $14M | $17M | $17M | $20M | $22M | |
| SG&A Expense | $11M | $10M | $11M | $11M | $12M | $12M | $13M | $14M | $16M | $13M | $12M | $12M | $13M | $15M | $12M | $13M | |
| Operating Expenses | $26M | $23M | $28M | $28M | $28M | $28M | $29M | $29M | $31M | $29M | $26M | $41M | $34M | $37M | $44M | $45M | |
| Operating Income | $-11M | $-8M | $11M | $-19M | $-13M | $-20M | $-7M | $-17M | $-23M | $-12M | $282.0K | $-32M | $-13M | $-24M | $-13M | $-11M | |
| Interest Income | $535.0K | $665.0K | $656.0K | $634.0K | $584.0K | $751.0K | $940.0K | $849.0K | $972.0K | $909.0K | $906.0K | $1M | $1M | $1M | $823.0K | $436.0K | |
| Other Non-op | $-1M | $-1M | $-2M | $-1M | $-984.0K | $-942.0K | $-4M | $-5M | $-985.0K | $-516.0K | $-8M | $-4M | $-9.0K | $-25.0K | $-26.0K | $216.0K | |
| Pretax Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-11M | $-7M | $-35M | $-12M | $-23M | $-12M | $-10M | |
| Income Tax | $10.0K | $36.0K | $18.0K | $8.0K | $10.0K | $11.0K | $4.0K | $10.0K | $10.0K | $10.0K | $35.0K | $9.0K | $9.0K | $16.0K | $151.0K | $8.0K | |
| Net Income | $-12M | $-9M | $10M | $-20M | $-13M | $-21M | $-10M | $-21M | $-23M | $-12M | $-7M | $-35M | $-12M | $-23M | $-13M | $-10M | |
| EPS (Basic) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| EPS (Diluted) | $-0.13 | $-0.10 | $0.13 | $-0.22 | $-0.16 | $-0.25 | $-0.12 | $-0.29 | $-0.32 | $-0.16 | $-0.11 | $-0.50 | $-0.17 | $-0.34 | $-0.19 | $-0.15 | |
| Shares (Basic) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| Shares (Diluted) | 91,053,000 | 90,768,000 | -170,908,000 | 90,251,000 | 85,389,000 | 82,410,000 | -138,854,000 | 72,032,000 | 70,376,000 | 69,854,000 | -134,839,000 | 69,466,000 | 67,573,000 | 65,931,000 | -130,466,000 | 65,426,000 | |
| EBITDA | $-11M | · | · | $-19M | $-13M | $-19M | · | $-17M | $-23M | $-12M | · | $-32M | $-13M | $-24M | · | $-11M |
Bilanz 27
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $37M | $51M | $25M | $27M | $18M | $19M | $37M | $19M | $58M | $65M | $75M | $92M | $103M | $114M | $109M | |
| Short-term Investments | $28M | $29M | $27M | $33M | $40M | $41M | $54M | $53M | $55M | $27M | · | · | · | · | · | · | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Prepaid Expense | $3M | $4M | $6M | $5M | $3M | $4M | $4M | $3M | $3M | $5M | · | $5M | $4M | $5M | · | $5M | |
| Other Current Assets | $500.0K | $400.0K | $500.0K | $500.0K | $100.0K | $500.0K | $500.0K | $300.0K | $900.0K | $500.0K | · | · | · | · | · | · | |
| Current Assets | $72M | $80M | $97M | $76M | $89M | $78M | $99M | $113M | $91M | $108M | · | $103M | $120M | $130M | · | $146M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $14M | $13M | $14M | $15M | · | $15M | $23M | $24M | · | $23M | |
| PP&E (Gross) | $59M | $59M | $58M | $58M | $58M | $57M | $55M | $54M | $54M | $55M | · | $54M | $66M | $65M | · | $63M | |
| Accum. Depreciation | $47M | $46M | $45M | $44M | $43M | $42M | $41M | $41M | $40M | $40M | · | $39M | $42M | $41M | · | $39M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | $1M | $994.0K | $883.0K | $912.0K | $950.0K | $967.0K | $1M | $2M | $2M | $1M | · | $726.0K | $498.0K | $415.0K | · | $208.0K | |
| Total Assets | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Accounts Payable | $3M | $2M | $2M | $2M | $1M | $6M | $3M | $4M | $4M | $3M | · | $3M | $4M | $4M | · | $3M | |
| Accrued Liabilities | $3M | $3M | $3M | $3M | $3M | $5M | $6M | $7M | $5M | $5M | · | $9M | $7M | $8M | · | $13M | |
| Current Liabilities | $24M | $15M | $25M | $18M | $15M | $21M | $24M | $35M | $31M | $29M | · | $38M | $36M | $38M | · | $32M | |
| Capital Leases | $28M | $29M | $30M | $26M | $27M | $27M | $28M | $9M | $10M | $11M | · | $13M | $35M | $37M | · | $40M | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $87M | $86M | $97M | $85M | $83M | $79M | $82M | $75M | $71M | $70M | · | $63M | $83M | $92M | · | $81M | |
| Long-term Debt | $41M | $40M | $40M | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Total Debt | $41M | · | · | $40M | $39M | $29M | · | $29M | $28M | $28M | · | · | · | · | · | · | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $660M | $659M | $657M | $655M | $652M | $633M | $630M | $626M | $593M | $588M | · | $582M | $580M | $570M | · | $563M | |
| Retained Earnings | $-627M | $-615M | $-607M | $-616M | $-597M | $-583M | $-563M | $-552M | $-532M | $-509M | · | $-490M | $-455M | $-444M | · | $-409M | |
| AOCI | $-13.0K | $-11.0K | $8.0K | $12.0K | $-3.0K | $14.0K | $52.0K | $126.0K | $-23.0K | $-16.0K | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $43M | $51M | $39M | $56M | $50M | $67M | $73M | $61M | $79M | $87M | $92M | $124M | $126M | $145M | $154M | |
| Liabilities + Equity | $120M | $129M | $148M | $124M | $138M | $129M | $149M | $148M | $132M | $150M | · | $154M | $207M | $218M | · | $235M | |
| Shares Outstanding | 91,388,000 | 90,894,000 | 90,478,000 | 90,281,000 | 90,254,000 | 82,841,000 | 81,850,000 | 81,376,000 | 70,914,000 | 70,554,000 | · | 69,827,000 | 69,804,000 | 66,696,000 | · | 65,613,000 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | · | · | · | |
| Stock-based Comp | $2M | $1M | $2M | $3M | $3M | $2M | $3M | $3M | $5M | $3M | $2M | $2M | $3M | $3M | $3M | $5M | |
| Restructuring | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $72.0K | $72.0K | $3M | $0 | |
| Other Non-cash | · | · | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-10M | $-13M | $20M | $-8M | $-18M | $-14M | $-16M | $-13M | $-12M | $-8M | $-11M | $-16M | $-16M | $-9M | $5M | $20M | |
| CapEx | $898.0K | $176.0K | $520.0K | $182.0K | $3M | $1M | $2M | $1M | $395.0K | $1M | $-380.0K | $678.0K | $2M | $3M | $-33.0K | $1M | |
| Investing Cash Flow | $175.0K | $-1M | $6M | $6M | $-367.0K | $12M | $-3M | $2M | $-27M | $-29M | $1M | $-1M | $-2M | $-3M | $33.0K | $-1M | |
| Debt Issued | · | · | $0 | $0 | $10M | $0 | $0 | $0 | $0 | $30M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $30M | · | · | · | · | · | · | |
| Stock Issued | · | · | $-1.0K | $0 | · | · | $-1.0K | $31M | $0 | $0 | $0 | $0 | $7M | $2M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $2M | · | · | |
| Financing Cash Flow | $66.0K | $-14.0K | $180.0K | $-111.0K | $27M | $1M | $1M | $30M | $-197.0K | $29M | $0 | $-108.0K | $7M | $1M | $339.0K | $133.0K | |
| Net Change in Cash | $-9M | $-14M | $26M | $-1M | $8M | $-944.0K | $-18M | $19M | $-39M | $-7M | $-10M | $-18M | $-11M | $-11M | $5M | $19M | |
| Taxes Paid | · | · | · | · | · | $0 | · | · | · | $17.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | $-15M | · | · | · | $-9M | · | · | · | $-12M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -75.3% | · | · | -220.3% | -83.9% | -271.6% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| Net Margin | -80.5% | · | · | -228.1% | -86.6% | -274.3% | · | -160.8% | -285.2% | -67.4% | · | -376.3% | -54.0% | -174.2% | · | -29.0% | |
| Pretax Margin | -80.4% | · | · | -228.0% | -86.5% | -274.1% | · | -160.8% | -285.1% | -67.3% | · | -376.2% | -54.0% | -174.1% | · | -29.0% | |
| EBITDA Margin | -75.3% | · | · | -220.3% | -83.9% | -255.8% | · | -129.0% | -284.9% | -69.6% | · | -345.6% | -59.2% | -182.3% | · | -30.9% | |
| ROA | -9.3% | · | · | -14.4% | -9.8% | -14.9% | · | -13.6% | -13.4% | -6.3% | · | -17.9% | -5.2% | -10.0% | · | -4.3% | |
| ROE | -27.1% | · | · | -35.0% | -22.7% | -32.1% | · | -25.0% | -24.5% | -11.2% | · | -28.4% | -8.1% | -15.9% | · | -6.2% | |
| ROIC | -15.2% | · | · | -24.2% | -13.6% | -26.0% | · | -16.2% | -25.3% | -11.1% | · | -35.0% | -10.2% | -18.8% | · | -6.9% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | · | 4.1 | 5.8 | 3.7 | · | 3.2 | 3.0 | 3.7 | · | 2.7 | 3.4 | 3.4 | · | 4.6 | |
| Quick Ratio | 2.3 | · | · | 3.2 | 4.4 | 2.9 | · | 2.6 | 2.4 | 2.9 | · | 1.9 | 2.6 | 2.7 | · | 3.4 | |
| Debt / Equity | 1.2 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · | |
| LT Debt / Equity | 1.0 | · | · | 1.0 | 0.7 | 0.6 | · | 0.4 | 0.5 | 0.4 | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 2.0 | · | · | 1.2 | 1.0 | 1.3 | · | 2.0 | 1.6 | 2.2 | · | 1.1 | 1.7 | 2.5 | · | 7.2 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $47M | · | $44M | $44M | $45M | · | $47M | $56M | $61M | · | $78M | $107M | $121M | · | $145M | |
| Net Income TTM | $-54M | $-62M | · | $-74M | $-77M | $-76M | · | $-90M | $-81M | $-81M | · | $-79M | $-47M | $-44M | · | $-19M | |
| Market Cap | $207M | · | · | $220M | $220M | $223M | · | $251M | $220M | $246M | · | $132M | $195M | $276M | · | $398M | |
| Enterprise Value | $192M | · | · | $201M | $193M | $192M | · | $189M | $175M | $189M | · | · | · | · | · | · | |
| P/E | -3.7 | -2.2 | · | -2.7 | -2.4 | -2.6 | · | -2.4 | -2.7 | -3.0 | · | -1.6 | -4.0 | -6.3 | · | -20.9 | |
| P/S | 3.8 | · | · | 5.0 | 5.0 | 4.9 | · | 5.3 | 4.0 | 4.1 | · | 1.7 | 1.8 | 2.3 | · | 2.7 | |
| P/B | 6.3 | · | · | 5.7 | 4.0 | 4.5 | · | 3.4 | 3.6 | 3.1 | · | 1.4 | 1.6 | 2.2 | · | 2.6 | |
| P / Tangible Book | 6.8 | 3.6 | · | 6.1 | 4.1 | 4.7 | · | 3.5 | 3.7 | 3.2 | · | 1.5 | 1.6 | 2.2 | · | 2.6 | |
| P / Cash Flow | · | · | · | · | · | -16.2 | · | · | · | -31.6 | · | · | · | -30.0 | · | · | |
| P / FCF | · | · | · | · | · | -14.8 | · | · | · | -27.6 | · | · | · | -23.5 | · | · | |
| EV / EBITDA | -17.1 | · | · | -10.6 | -15.0 | -10.0 | · | -11.4 | -7.7 | -15.9 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -12.8 | · | · | · | -21.2 | · | · | · | · | · | · | |
| EV / Revenue | 3.6 | · | · | 4.5 | 4.4 | 4.2 | · | 4.0 | 3.1 | 3.1 | · | · | · | · | · | · | |
| Earnings Yield | -27.0% | -44.8% | · | -37.7% | -41.8% | -37.9% | · | -41.2% | -37.1% | -33.5% | · | -61.4% | -25.0% | -15.9% | · | -4.8% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $70M | $59M | $70M | $139M | $105M |
| Betriebsgewinnmarge % | -59.3% | -98.6% | -97.0% | -25.2% | -21.7% |
| Nettoergebnis | $-44M | $-65M | $-76M | $-34M | $-21M |
| Verwässerte EPS | $-0.50 | $-0.89 | $-1.12 | $-0.51 | $-0.33 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.8 | 0.4 | — | — | — |
| Liquiditätsgrad | 3.8 | 4.2 | 2.6 | 3.3 | 4.9 |
| Quick Ratio | 3.1 | 3.1 | 2.1 | 3.0 | 4.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-24M | $-54M | $-57M | $3M | $-28M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 156 Einreicher · $120.9M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (+4 vs. Vorquartal) | 11 (-10 vs. Vorquartal) | 50 (+4 vs. Vorquartal) | 41 (+8 vs. Vorquartal) | +6.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Opaleye Management Inc. | $15.334.100 | 6.785.000 | 12,69% | Aktien |
| Aberdeen Group plc | $15.300.096 | 6.769.954 | 12,66% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $12.541.054 | 5.549.139 | 10,38% | Aktien |
| Telemark Asset Management, LLC | $8.692.889 | 3.846.411 | 7,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $8.609.334 | 3.809.440 | 7,12% | Aktien |
| Nantahala Capital Management, LLC | $8.189.365 | 3.623.613 | 6,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.174.666 | 3.617.109 | 6,76% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.204.899 | 1.860.140 | 3,48% | Aktien |
| STATE STREET CORP | $3.970.400 | 1.756.814 | 3,29% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.006.263 | 1.330.205 | 2,49% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.954.206 | 1.307.171 | 2,44% | Aktien |
| Assenagon Asset Management S.A. | $2.888.746 | 1.278.206 | 2,39% | Aktien |
| D. E. Shaw & Co., Inc. | $2.500.229 | 1.106.296 | 2,07% | Aktien |
| Tallon Kerry Patrick | $2.018.337 | 403.667 | 1,67% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.574.314 | 696.599 | 1,30% | Aktien |
| FRANKLIN RESOURCES INC | $1.533.726 | 678.640 | 1,27% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.313.191 | 581.058 | 1,09% | Aktien |
| Man Group plc | $1.278.240 | 565.593 | 1,06% | Aktien |
| Post Resch Tallon Group Inc. | $1.273.460 | 563.478 | 1,05% | Aktien |
| PERKINS CAPITAL MANAGEMENT INC | $1.188.986 | 526.100 | 0,98% | Aktien |
| ALGERT GLOBAL LLC | $973.857 | 430.910 | 0,81% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $808.910 | 357.925 | 0,67% | Aktien |
| BlackRock, Inc. | $648.681 | 287.027 | 0,54% | Aktien |
| PLATINUM INVESTMENT MANAGEMENT LTD | $597.689 | 264.464 | 0,49% | Aktien |
| Potomac Capital Management, Inc. | $587.600 | 260.000 | 0,49% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $583.674 | 258.263 | 0,48% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $547.397 | 242.211 | 0,45% | Aktien |
| XTX Topco Ltd | $543.817 | 240.627 | 0,45% | Aktien |
| UBS Group AG | $542.188 | 239.906 | 0,45% | Aktien |
| FMR LLC | $457.501 | 202.434 | 0,38% | Aktien |
| GOLDMAN SACHS GROUP INC | $389.726 | 172.445 | 0,32% | Aktien |
| Cubist Systematic Strategies, LLC | $359.610 | 147.381 | 0,30% | Aktien |
| BARCLAYS PLC | $347.740 | 153.867 | 0,29% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $334.595 | 148.051 | 0,28% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $284.552 | 125.908 | 0,24% | Aktien |
| STRS OHIO | $273.460 | 121.000 | 0,23% | Aktien |
| JANE STREET GROUP, LLC | $261.857 | 115.866 | 0,22% | Aktien |
| MARSHALL WACE, LLP | $254.791 | 112.739 | 0,21% | Aktien |
| Stonepine Capital Management, LLC | $247.836 | 109.662 | 0,21% | Aktien |
| RHUMBLINE ADVISERS | $233.449 | 103.301 | 0,19% | Aktien |
| CITADEL ADVISORS LLC | $227.295 | 100.573 | 0,19% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $206.081 | 126.430 | 0,17% | Aktien |
| WELLS FARGO & COMPANY/MN | $176.113 | 77.926 | 0,15% | Aktien |
| Bank of New York Mellon Corp | $174.178 | 77.070 | 0,14% | Aktien |
| LPL Financial LLC | $173.026 | 76.560 | 0,14% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $161.879 | 71.628 | 0,13% | Aktien |
| BANK OF AMERICA CORP /DE/ | $145.582 | 64.417 | 0,12% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $144.082 | 63.753 | 0,12% | Aktien |
| Numerai GP LLC | $136.072 | 60.209 | 0,11% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $131.532 | 58.200 | 0,11% | Aktien |
| Mariner, LLC | $123.484 | 54.637 | 0,10% | Aktien |
| MetLife Investment Management, LLC | $117.545 | 52.011 | 0,10% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $116.108 | 51.375 | 0,10% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $108.763 | 48.125 | 0,09% | Aktien |
| IEQ CAPITAL, LLC | $104.559 | 46.265 | 0,09% | Aktien |
| TWO SIGMA ADVISERS, LP | $96.822 | 59.400 | 0,08% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $93.790 | 41.500 | 0,08% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $89.957 | 39.804 | 0,07% | Aktien |
| CITIGROUP INC | $86.660 | 38.345 | 0,07% | Aktien |
| Frec Markets, Inc. | $84.228 | 37.269 | 0,07% | Aktien |
| OSAIC HOLDINGS, INC. | $82.186 | 36.366 | 0,07% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $81.820 | 36.204 | 0,07% | Aktien |
| BANK OF MONTREAL /CAN/ | $79.095 | 34.998 | 0,07% | Aktien |
| Krilogy Financial LLC | $78.705 | 34.825 | 0,07% | Aktien |
| MORGAN STANLEY | $77.462 | 34.275 | 0,06% | Aktien |
| Invesco Ltd. | $77.181 | 34.151 | 0,06% | Aktien |
| Dynamic Technology Lab Private Ltd | $74.000 | 33.000 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $73.681 | 32.602 | 0,06% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $73.111 | 32.350 | 0,06% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $68.932 | 30.501 | 0,06% | Aktien |
| BLAIR WILLIAM & CO/IL | $68.295 | 30.219 | 0,06% | Aktien |
| EVERGREEN CAPITAL MANAGEMENT LLC | $65.540 | 29.000 | 0,05% | Aktien |
| CWM, LLC | $63.696 | 39.077 | 0,05% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $61.418 | 25.275 | 0,05% | Aktien |
| Nuveen Asset Management, LLC | $59.902 | 12.558 | 0,05% | Aktien |
| PRUDENTIAL FINANCIAL INC | $59.619 | 26.380 | 0,05% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $56.963 | 25.205 | 0,05% | Aktien |
| Cerity Partners LLC | $53.695 | 23.759 | 0,04% | Aktien |
| VANGUARD GROUP INC | $53.141 | 32.602 | 0,04% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $48.486 | 21.454 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $45.426 | 20.100 | 0,04% | Kaufoption |
| Police & Firemen's Retirement System of New Jersey | $43.937 | 19.441 | 0,04% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $41.948 | 18.561 | 0,03% | Aktien |
| Vanguard Personalized Indexing Management, LLC | $40.562 | 17.948 | 0,03% | Aktien |
| Simplicity Wealth,LLC | $39.410 | 17.438 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $38.167 | 16.888 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $35.708 | 15.800 | 0,03% | Kaufoption |
| Creative Planning | $35.003 | 15.488 | 0,03% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $34.942 | 15.461 | 0,03% | Aktien |
| Navalign, LLC | $34.668 | 15.340 | 0,03% | Aktien |
| EP Wealth Advisors, LLC | $34.526 | 15.277 | 0,03% | Aktien |
| China Universal Asset Management Co., Ltd. | $32.693 | 14.466 | 0,03% | Aktien |
| ProShare Advisors LLC | $32.324 | 14.303 | 0,03% | Aktien |
| Elmwood Wealth Management, Inc. | $28.691 | 12.695 | 0,02% | Aktien |
| NORTHERN TRUST CORP | $27.992 | 12.386 | 0,02% | Aktien |
| OXFORD ASSET MANAGEMENT LLP | $27.335 | 12.095 | 0,02% | Aktien |
| Graham Capital Management, L.P. | $27.287 | 12.074 | 0,02% | Aktien |
| Tower Research Capital LLC (TRC) | $27.244 | 12.055 | 0,02% | Aktien |
| Abel Hall, LLC | $26.930 | 11.916 | 0,02% | Aktien |
| Caerus Investment Advisors, LLC | $26.297 | 11.636 | 0,02% | Aktien |
Unternehmensinsider 40 Insider · 19 Führungskräfte · 20 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John J Nicols | President and CEO | 11. Juni 2018 M | 1.072.679 | 0 | 0 | $0 |
| Peter M Strumph | Interim President and CEO | 1. Juni 2012 A | 60.756 | 0 | 0 | $0 |
| Alan Shaw | President and CEO | 16. Dezember 2011 S | 202.000 | 0 | 0 | $0 |
| Georgia Erbez | Chief Financial Officer | 5. Februar 2025 A | 76.875 | 0 | 0 | $0 |
| Sriram Ryali | Chief Financial Officer | 1. Januar 2024 A | 175.791 | 0 | 0 | $0 |
| Gordon Sangster | SVP & Chief Financial Officer | 24. Mai 2018 S | 153.189 | 0 | 0 | $0 |
| David D O'Toole | SVP & Chief Financial Officer | 4. September 2013 F | 110.687 | 0 | 0 | $0 |
| Brian Paul Dowd | Interim CFO | 1. Juni 2012 A | 28.310 | 0 | 0 | $0 |
| Robert J Lawson | SVP and CFO | 11. Mai 2011 P | 44.000 | 0 | 0 | $0 |
| Kevin Norrett | Chief Operating Officer | 5. Februar 2025 A | 177.327 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 5. Februar 2025 A | 175.571 | 0 | 0 | $0 |
| Margaret Nell Fitzgerald | Chief Legal and Compliance Officer | 1. Januar 2024 A | 133.770 | 0 | 0 | $0 |
| James Lalonde | SVP, R&D | 17. Juli 2018 S | 195.066 | 0 | 0 | $0 |
| Michael D. Aldridge | Senior Vice President, Corporate & Strategic Development | 17. Mai 2018 M | 0 | 0 | 0 | $0 |
| Douglas T. Sheehy | EVP, Chief Administrative Officer, General Counsel & Secretary | 5. März 2016 F | 247.617 | 0 | 0 | $0 |
| Matthew Tobin | SVP, Research & Development | 16. Mai 2013 M | 78.707 | 0 | 0 | $0 |
| David L. Anton | SVP, BioIndustrials | 10. Februar 2013 F | 93.777 | 0 | 0 | $0 |
| Seufer-Wasserthal Peter | SVP, Pharmaceuticals | 24. Januar 2013 A | 93.064 | 0 | 0 | $0 |
| Joseph J. Sarret | SVP and CBO | 7. März 2012 A | 74.000 | 0 | 0 | $0 |
| Raymond De Vre | Direktor | 17. Juni 2026 A | 84.811 | 0 | 1 | $-6.174 |
| Esther Martinborough | Direktor | 17. Juni 2026 A | 129.036 | 0 | 0 | $0 |
| Christos Richards | Direktor | 17. Juni 2026 A | 85.133 | 0 | 0 | $0 |
| Cynthia Collins | Direktor | 17. Juni 2026 A | 112.157 | 0 | 0 | $0 |
| Stephen George Dilly | Direktor | 17. Juni 2026 A | 673.053 | 0 | 0 | $0 |
| Rahul Singhvi | Direktor | 17. Juni 2026 A | 137.052 | 0 | 0 | $0 |
| David V Smith | Direktor | 17. Juni 2026 A | 105.705 | 0 | 0 | $0 |
| PARKER H STEWART | Direktor | 17. Juni 2026 A | 143.583 | 0 | 0 | $0 |
| Dennis P Wolf | Direktor | 10. Juni 2025 A | 147.903 | 0 | 0 | $0 |
| Byron L Dorgan | Direktor | 11. Juni 2024 A | 223.581 | 0 | 0 | $0 |
| Patrick Y Yang | Direktor | 19. Juli 2018 S | 304.157 | 0 | 0 | $0 |
| Kathleen Sereda Glaub | Direktor | 18. Juli 2018 S | 98.120 | 0 | 0 | $0 |
| Thomas R Baruch | Direktor | 26. Juni 2018 S | 153.093 | 0 | 0 | $0 |
| Bernard J Kelley | Direktor | 21. Juni 2018 S | 225.668 | 0 | 0 | $0 |
| Pam P. Cheng | Direktor | 11. Juni 2018 A | 64.642 | 0 | 0 | $0 |
| Alexander Karsner | Direktor | 2. Januar 2014 A | 78.519 | 0 | 0 | $0 |
| Bruce A Pasternack | Direktor | 24. August 2010 P | 10.000 | 0 | 0 | $0 |
| James R Sulat | Direktor | 27. April 2010 J | 5.957.108 | 0 | 0 | $0 |
| Brazil Holding B.V. Shell | 10%-Eigentümer | 31. Mai 2011 J | 5.573.319 | 0 | 0 | $0 |
| Equilon Enterprises LLC | 10%-Eigentümer | 20. Mai 2011 J | 5.573.319 | 0 | 0 | $0 |
| MAXYGEN INC | 10%-Eigentümer | 14. Dezember 2010 J | 524.643 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| John Nicols | 16. Februar 2021 | — | Erste Einreichung | — | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAÍZEN ENERGIA S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON SHELL BRAZIL HOLDING B.V., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COMÉRCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN INVESTIMENTOS E PARTICIPAÇÕES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED ×2 Einreichungen | 26. Mai 2015 | — | Erste Einreichung | — | SEC |
| – I.RS. IDENTIFICATION NO. OF ABOVE PERSON RAIZEN ENERGIA PARTICIPA Ç Õ ES S.A., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ISPAGNAC PARTICIPA Ç Õ ES LTDA., – I.RS. IDENTIFICATION NO. OF ABOVE PERSON ROYAL DUTCH SHELL PLC, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN S.A. INDUSTRIA E COM É RCIO, – I.RS. IDENTIFICATION NO. OF ABOVE PERSON COSAN LIMITED | 7. Juni 2011 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 26 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,26% | 40.370 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 290.804 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,01% | 3.341 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 496.936 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78.444 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 613.531 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,01% | 4.900 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 38.712 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 679.206 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 4.198 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 2.240.076 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,00% | 3.283 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 71.405 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28.868 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 3.320 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 128.823 SH | 8. August 2026 | Täglich |
| HDG · ProShares Trust | 0,00% | 83 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 52.788 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2.554 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.729 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.926 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 19.277 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 895.869 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.633.770 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.454 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.744 SH | 8. August 2026 | Täglich |